Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
- 1 September 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 112 (5) , 2149-2155
- https://doi.org/10.1182/blood-2007-12-127449
Abstract
Although interaction between programmed death-1 (PD-1) and the ligand PD-L1 has been shown to mediate CD8 cell exhaustion in the setting of chronic infection or the absence of CD4 help, a role for this pathway in attenuating early alloreactive CD8 cell responses has not been identified. We demonstrate that the PD-1/PD-L1 pathway is needed to rapidly tolerize alloreactive CD8 cells in a model that requires CD4 cells and culminates in CD8 cell deletion. This protocol involves allogeneic bone marrow transplantation (BMT) following conditioning with low-dose total body irradiation and anti-CD154 antibody. Tolerized donor-reactive T-cell receptor transgenic CD8 cells are shown to be in an abortive activation state prior to their deletion, showing early and prolonged expression of activation markers (compared with rejecting CD8 cells) while being functionally silenced by day 4 after transplantation. Although both tolerized and rejecting alloreactive CD8 cells up-regulate PD-1, CD8 cell tolerance is dependent on the PD-1/PD-L1 pathway. In contrast, CD4 cells are tolerized independently of this pathway following BMT with anti-CD154. These studies demonstrate a dichotomy between the requirements for CD4 and CD8 tolerance and identify a role for PD-1 in the rapid tolerization of an alloreactive T-cell population via a deletional mechanism.Keywords
This publication has 32 references indexed in Scilit:
- Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class IIThe Journal of Immunology, 2008
- Striking Dichotomy of PD-L1 and PD-L2 Pathways in Regulating Alloreactive CD4+ and CD8+ T Cells In VivoAmerican Journal of Transplantation, 2007
- PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft RejectionThe Journal of Immunology, 2007
- CD40-CD40 Ligand Interaction between Dendritic Cells and CD8+ T Cells Is Needed to Stimulate Maximal T Cell Responses in the Absence of CD4+ T Cell HelpThe Journal of Immunology, 2007
- The function of programmed cell death 1 and its ligands in regulating autoimmunity and infectionNature Immunology, 2007
- Expression of Programmed Death 1 Ligands by Murine T Cells and APCThe Journal of Immunology, 2002
- CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this PathwayThe Journal of Immunology, 2001
- PD-L2 is a second ligand for PD-1 and inhibits T cell activationNature Immunology, 2001
- Peripheral Deletion After Bone Marrow Transplantation with Costimulatory Blockade Has Features of Both Activation-Induced Cell Death and Passive Cell DeathThe Journal of Immunology, 2001
- CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft RejectionThe Journal of Immunology, 2000